Eyantra Ventures Limited

Eyantra Ventures Limited

BBSE:EY
513.00
INR
0.00
(0.00%)
-25.26EPS
1.37BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
181.36
23.73
86.11
56.73
126.84
39.87
48.45
53.18
10.99
34.52
100.36
176.55
469.51
467.07
Basic EPS, GAAP
-0.24
0.08
-1.79
0.87
-1.49
0.01
0.17
2.02
0.29
3.64
6.38
4.05
-22.98
-16.06
Free Cash Flow per Basic Share
5.09
10.17
-1.96
0.56
5.92
5.44
-3.25
0.28
1.22
-0.14
-3.67
-6.7
-86.01
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
10.71
10.79
9
9.9
8.42
8.43
8.6
10.61
10.91
14.55
67.46
139.24
141.25
- -
Tangible Book Value per Share
10.71
10.79
9
9.9
8.42
8.43
8.6
10.61
10.91
14.55
48.45
122.83
62
- -
Basic Weighted Avg Shares
1
1
1
1
1
1
1
1
1
1
2
2
2
2
Sales/Revenue/Turnover
261
34
124
82
183
57
70
77
16
50
168
327
942
938
Operating Margin (%)
0.34
-14
0.05
4.46
-0.86
0.05
-0.18
3.7
1.86
13.83
8.03
4.98
-3.81
-4.1
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
4
40
40
Net Income, GAAP
- -
- -
-3
1
-2
- -
- -
3
- -
5
11
8
-46
-32
Effective Tax Rate (%)
5,346.38
- -
- -
19.36
- -
- -
29.23
- -
- -
22.4
29.24
43.36
- -
- -
Profit Margin (%)
-0.13
0.32
-2.08
1.54
-1.17
0.03
0.35
3.79
2.67
10.56
6.35
2.3
-4.9
-3.44
Working Capital
13
31
24
26
16
12
12
15
11
16
89
186
79
- -
LT Debt
- -
18
13
13
5
- -
- -
- -
- -
- -
- -
6
86
- -
Total Equity
15
16
13
14
12
12
12
15
16
21
123
279
290
- -
Return on Invested Capital (%)
-231.09
- -
- -
10.68
- -
- -
-0.72
- -
1.9
24.29
10.45
4.46
- -
- -
Return on Capital (%)
-8.79
- -
- -
8.58
- -
- -
2.14
- -
2.73
28.62
14.81
3.92
- -
- -
Return on Common Equity (%)
-2.23
0.71
-18.08
9.21
-16.23
0.12
2.01
20.98
2.72
28.62
14.82
3.73
-16.39
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
79
- -
LT Borrowings
- -
50
- -
LT Finance Leases
- -
36
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2
2
2
Market Capitalization
1,947
1,846
1,370

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
348
- -
Cash, Cash Equivalents & STI
- -
17
- -
Accounts Receivable, Net
- -
280
- -
Inventories
- -
16
- -
Total Current Liabilities
- -
268
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
79
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
67.42%
130.71%
3.95%
Free Cash Flow
512.26%
916.06%
1,291.51%
Net Income, GAAP
252.41%
83.38%
-714.43%
Sales/Revenue/Turnover
70.72%
131.02%
188.12%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
59
76
113
78
327
2026
196
229
264
253
942
2027
192
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
4.49
1.88
0.59
-2.78
4.05
2026
-8.6
-22.05
-18.33
33.78
-22.98
2027
-9.44
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Rameshkumar Lalitkumar Shah
Full Time Employees
37
Sector
Consumer durables
Industry
Other consumer specialties
Address
301, CSR Estate Hyderabad TS India 500081
IPO Date
Aug 17, 2005
Business
Eyantra Ventures Ltd. operates as a diversified holding company focused on merchandise solutions, technology services, and healthcare, providing custom corporate gifting, branded merchandise, employee rewards and recognition platforms, AI-driven IT services including software development, GenAI solutions, cloud services, cybersecurity, and mobile applications through subsidiaries such as Prismberry Technologies and eYantra; it also manages specialized hospitals for brain, spine, orthopaedics, and trauma care via Neuro and Spine Associates. The company serves enterprise clients with B2B marketing strategies, experiential gifting in categories like adventure, food, and travel, and digital transformation tools for predictive analytics and automation, targeting businesses across India, UAE, Dubai, and international markets. Founded in 1984 and headquartered in Hyderabad, India, at 301, 3rd Floor, CSR Estate, HUDA Techno Enclave, Madhapur, Eyantra Ventures maintains operations in Southeast Asia with expansion into wellness tech. Recent developments include a preferential issue raising Rs 15 crore in late 2024 to fund global expansion and strategic investments; acquisition of 100% stake in Prismberry Technologies Private Limited for IT capabilities; 60% controlling stake in Neuro and Spine Associates Private Limited in 2024, later adjusted to 38.65% by March 2025, marking entry into healthcare with facilities in Hyderabad, Bangalore, and Vijayawada; establishment of a wholly owned subsidiary in the UAE for international IT/ITES growth; and a name change from Punit Commercials Limited to pursue diversified ventures.